Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedAug 03, 2026
DataAggregated Company Financials
Companies16
  • 7D-1.8%
  • 3M-1.7%
  • 1Y16.3%
  • YTD-3.7%

Over the last 7 days, the Pharma industry has dropped 1.8%, driven by a pullback from AstraZeneca of 0.3%. Over the past 12 months, the industry was up 16%. Looking forward, earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 04 Aug 2026UK£310.7bUK£92.9bUK£14.4b22.5x21.5x3.3x
Thu, 02 Jul 2026UK£328.1bUK£92.5bUK£15.9b18.5x20.6x3.5x
Sat, 30 May 2026UK£324.7bUK£91.8bUK£15.8b17.9x20.6x3.5x
Mon, 27 Apr 2026UK£334.5bUK£90.2bUK£15.5b19x21.6x3.7x
Wed, 25 Mar 2026UK£330.1bUK£90.7bUK£15.6b20.9x21.1x3.6x
Fri, 20 Feb 2026UK£368.6bUK£90.4bUK£15.4b23.8x23.9x4.1x
Sun, 18 Jan 2026UK£329.1bUK£89.7bUK£14.6b21.3x22.5x3.7x
Tue, 16 Dec 2025UK£323.0bUK£89.7bUK£14.6b21.6x22.1x3.6x
Thu, 13 Nov 2025UK£322.5bUK£90.5bUK£14.8b22.1x21.8x3.6x
Sat, 11 Oct 2025UK£300.1bUK£88.0bUK£11.8b19.8x25.5x3.4x
Mon, 08 Sep 2025UK£285.8bUK£87.5bUK£11.7b22x24.4x3.3x
Wed, 06 Aug 2025UK£268.5bUK£88.1bUK£11.5b28.1x23.4x3x
Fri, 04 Jul 2025UK£254.8bUK£86.0bUK£10.6b25.5x24.1x3x
Sun, 01 Jun 2025UK£271.4bUK£86.5bUK£10.6b27.3x25.5x3.1x
Tue, 29 Apr 2025UK£261.1bUK£86.0bUK£9.5b27.4x27.4x3x
Thu, 27 Mar 2025UK£276.1bUK£87.9bUK£9.7b31.9x28.5x3.1x
Sat, 22 Feb 2025UK£283.5bUK£88.7bUK£9.4b30.9x30x3.2x
Mon, 20 Jan 2025UK£232.8bUK£76.8bUK£8.0b31.8x29.3x3x
Wed, 18 Dec 2024UK£224.6bUK£74.8bUK£7.7b31.6x29.1x3x
Fri, 15 Nov 2024UK£222.0bUK£75.0bUK£7.7b30.9x28.7x3x
Sun, 13 Oct 2024UK£250.3bUK£72.2bUK£9.0b31.1x27.7x3.5x
Tue, 10 Sep 2024UK£272.4bUK£72.2bUK£9.0b40x30.2x3.8x
Thu, 08 Aug 2024UK£267.0bUK£73.3bUK£9.1b38.8x29.4x3.6x
Sat, 06 Jul 2024UK£256.0bUK£71.2bUK£9.5b31.6x26.9x3.6x
Mon, 03 Jun 2024UK£268.8bUK£71.4bUK£9.6b31.8x28.1x3.8x
Wed, 01 May 2024UK£263.1bUK£71.8bUK£10.1b31.5x26.2x3.7x
Fri, 29 Mar 2024UK£245.1bUK£70.8bUK£9.7b31.8x25.2x3.5x
Sun, 25 Feb 2024UK£236.1bUK£70.6bUK£9.6b33.7x24.5x3.3x
Tue, 23 Jan 2024UK£238.9bUK£68.9bUK£10.7b36.6x22.4x3.5x
Thu, 21 Dec 2023UK£232.9bUK£69.1bUK£10.7b34.9x21.8x3.4x
Sat, 18 Nov 2023UK£227.8bUK£69.8bUK£10.8b53.7x21.1x3.3x
Mon, 16 Oct 2023UK£245.7bUK£70.8bUK£10.4b56.6x23.7x3.5x
Wed, 13 Sep 2023UK£239.5bUK£69.7bUK£10.3b53.5x23.4x3.4x
Fri, 11 Aug 2023UK£244.0bUK£69.0bUK£10.2b52.8x24x3.5x
Price to Earnings Ratio

24x


Total Market Cap: UK£244.0bTotal Earnings: UK£10.2bTotal Revenue: UK£69.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 24.9x202420252026
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 21.5x which is lower than its 3-year average PE of 24.9x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 10% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.74%
Healthcare-1.67%
Pharma-1.81%
Pharma-1.81%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUK£19.320.6%
+UK£477.9m		38.3%PE16x
HCM HUTCHMED (China)UK£1.702.4%
+UK£50.2m		-35.6%PE111.3x
HIK Hikma PharmaceuticalsUK£15.850.2%
+UK£6.3m		-18.3%PE11.2x
POLB Poolbeg PharmaUK£0.0678.9%
+UK£4.2m		148.1%PB5.9x
SAR Sareum HoldingsUK£0.234.5%
+UK£1.4m		35.3%PB26.7x

Latest News

AZN
UK£126.32
AstraZeneca
7D
-0.3%
1Y
13.8%
STX
UK£0.04
Shield Therapeutics
7D
-35.8%
1Y
-12.2%
FUM
UK£0.0042
Futura Medical
7D
4.5%
1Y
-96.7%
HCM
UK£1.70
HUTCHMED (China)
7D
2.4%
1Y
-35.6%
HLN
UK£3.63
Haleon
7D
-0.06%
1Y
-0.6%
GSK
UK£19.32
GSK
7D
0.6%
1Y
38.3%
EAH
UK£1.00
ECO Animal Health Group
7D
-1.0%
1Y
34.2%
POLB
UK£0.067
Poolbeg Pharma
7D
8.9%
1Y
148.1%
SAR
UK£0.23
Sareum Holdings
7D
4.5%
1Y
35.3%
HIK
UK£15.85
Hikma Pharmaceuticals
7D
0.2%
1Y
-18.3%
Narrative Update • Jul 14

HIK: US Manufacturing Expansion Will Support Future Earnings Rebound

Analysts have trimmed their price target on Hikma Pharmaceuticals to £24.79 from £26.36, reflecting updated assumptions for slightly higher discount rates, more moderate revenue expectations, and a marginally softer profit margin and future P/E outlook. What’s in the News for Hikma Pharmaceuticals Hikma plans to invest $267 million to expand manufacturing operations in Columbus and Bedford, Ohio, with a target of creating 350 new jobs across injectable, oral solid dose, and nasal inhalation facilities.
THAT
UK£0.0067
Thalia Therapeutics
7D
-3.6%
1Y
50.0%
IMM
UK£0.036
ImmuPharma
7D
-20.4%
1Y
72.1%
NFX
UK£0.0014
Nuformix
7D
-14.7%
1Y
87.1%